Improvement in the renal prognosis in nephropathic cystinosis
- PMID: 21868618
- PMCID: PMC3359556
- DOI: 10.2215/CJN.02000311
Improvement in the renal prognosis in nephropathic cystinosis
Abstract
Background and objectives: Nephropathic cystinosis (NC) is an autosomal recessive disorder occurring in one to two per 100,000 newborns. Because of the rarity of NC, long-term outcome data are scarce.
Design, setting, participants, & measurements: 245 NC patients from 18 countries provided data to the ESPN/ERA-EDTA registry. We matched NC patients on renal replacement therapy (RRT) to non-NC children on RRT.
Results: Between 1979 and 2008, mean age at the start of RRT among NC children increased by 0.15 year per calendar year (95% confidence interval, 0.10 to 0.21) from 8.8 to 12.7 years, whereas we did not observe this in non-NC children. Five-year survival after the start of RRT improved in NC patients from 86.1% (before 1990) to 100% (since 2000) as compared with the control population (89.6% and 94.0%). NC patients received a renal allograft more often (relative risk, 1.09; 95% confidence interval, 1.00 to 1.17) as compared with matched RRT children, and 5-year graft survival was better (94.0% versus 84.0%). NC dialysis patients were less often hypertensive than non-NC children matched for age, country, and dialysis modality (42.7% versus 51.7%) and had lower parathyroid hormone levels (median, 56 versus 140 pg/ml). Although height at start of RRT slightly improved during the past decade, children with NC remained significantly shorter than non-NC children at the start of RRT.
Conclusions: We demonstrated improved survival of the renal function as well as better patient and graft survival after the start of RRT in a large European cohort of NC patients over the last two decades.
Figures


Similar articles
-
Lessons learned from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2016 Nov;31(11):2055-64. doi: 10.1007/s00467-015-3238-8. Epub 2015 Oct 24. Pediatr Nephrol. 2016. PMID: 26498279 Review.
-
Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy.Clin J Am Soc Nephrol. 2012 Mar;7(3):458-65. doi: 10.2215/CJN.07430711. Epub 2012 Jan 5. Clin J Am Soc Nephrol. 2012. PMID: 22223608 Free PMC article.
-
Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry.Am J Kidney Dis. 2015 Oct;66(4):613-20. doi: 10.1053/j.ajkd.2015.03.025. Epub 2015 May 12. Am J Kidney Dis. 2015. PMID: 25975963
-
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16. Am J Kidney Dis. 2019. PMID: 30122544
-
Nephropathic cystinosis: late complications of a multisystemic disease.Pediatr Nephrol. 2008 Jun;23(6):863-78. doi: 10.1007/s00467-007-0650-8. Pediatr Nephrol. 2008. PMID: 18008091 Review.
Cited by
-
Impact of compliance to oral cysteamine treatment on the costs of Kidney failure in patients with nephropathic cystinosis in the United Kingdom.BMC Nephrol. 2023 Nov 29;24(1):351. doi: 10.1186/s12882-023-03392-y. BMC Nephrol. 2023. PMID: 38031005 Free PMC article.
-
Chest configuration in children and adolescents with infantile nephropathic cystinosis compared with other chronic kidney disease entities and its clinical determinants.Pediatr Nephrol. 2023 Dec;38(12):3989-3999. doi: 10.1007/s00467-023-06058-x. Epub 2023 Jul 7. Pediatr Nephrol. 2023. PMID: 37415042 Free PMC article.
-
Detailed studies of growth hormone secretion in cystinosis patients.Pediatr Nephrol. 2012 Nov;27(11):2123-2127. doi: 10.1007/s00467-012-2213-x. Epub 2012 Jun 5. Pediatr Nephrol. 2012. PMID: 22664570
-
Lessons learned from the ESPN/ERA-EDTA Registry.Pediatr Nephrol. 2016 Nov;31(11):2055-64. doi: 10.1007/s00467-015-3238-8. Epub 2015 Oct 24. Pediatr Nephrol. 2016. PMID: 26498279 Review.
-
Excellent long-term outcome of renal transplantation in cystinosis patients.Orphanet J Rare Dis. 2015 Jul 25;10:90. doi: 10.1186/s13023-015-0307-9. Orphanet J Rare Dis. 2015. PMID: 26208493 Free PMC article.
References
-
- Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C: A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18: 319–324, 1998 - PubMed
-
- Cochat P, Cordier B, Lacôte C, Saïd MH: Cystinosis: Epidemiology in France. In: Cystinosis, edited by Broyer M. Paris, Elsevier, 1999, pp 28–35
-
- Gahl WA, Thoene JG, Schneider JA: Cystinosis. N Engl J Med 347:111–121, 2002 - PubMed
-
- Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA: Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316: 971–977, 1987 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous